CO5180571A1 - CRYSTALLINE FORM III OF THE N- (4-DIMETHYLAMINONAFTALEN-1 SULPHONYLAMINE) PHENYL) -3-HYDROXI-2,2-DIMETHYLPROPIONAMIDE - Google Patents

CRYSTALLINE FORM III OF THE N- (4-DIMETHYLAMINONAFTALEN-1 SULPHONYLAMINE) PHENYL) -3-HYDROXI-2,2-DIMETHYLPROPIONAMIDE

Info

Publication number
CO5180571A1
CO5180571A1 CO00054502A CO00054502A CO5180571A1 CO 5180571 A1 CO5180571 A1 CO 5180571A1 CO 00054502 A CO00054502 A CO 00054502A CO 00054502 A CO00054502 A CO 00054502A CO 5180571 A1 CO5180571 A1 CO 5180571A1
Authority
CO
Colombia
Prior art keywords
dimethylpropionamide
phenyl
crystalline form
form iii
dimethylaminonaftalen
Prior art date
Application number
CO00054502A
Other languages
Spanish (es)
Inventor
Alfons Grunenberg
Andreas Lender
Andree Folkerts
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CO5180571A1 publication Critical patent/CO5180571A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Forma cristalina III de la N-(4-(5-dimetilaminonaftalen-1-sulfonilamino)fenil)-3-hidroxi-2,2-dimetilpropionamida (DNSP) de fórmula.<EMI FILE="00054502_1" ID="1" IMF=JPEG >Crystalline form III of the N- (4- (5-dimethylaminonaphthalen-1-sulfonylamino) phenyl) -3-hydroxy-2,2-dimethylpropionamide (DNSP) of formula. <EMI FILE = "00054502_1" ID = "1" IMF = JPEG>

CO00054502A 1999-07-21 2000-07-19 CRYSTALLINE FORM III OF THE N- (4-DIMETHYLAMINONAFTALEN-1 SULPHONYLAMINE) PHENYL) -3-HYDROXI-2,2-DIMETHYLPROPIONAMIDE CO5180571A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19934295A DE19934295A1 (en) 1999-07-21 1999-07-21 New thermodynamically stable crystal modification III of N-phenyl-naphthalene-sulfonamide derivative, is an antiviral agent especially useful for treating cytomegalovirus infections

Publications (1)

Publication Number Publication Date
CO5180571A1 true CO5180571A1 (en) 2002-07-30

Family

ID=7915608

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00054502A CO5180571A1 (en) 1999-07-21 2000-07-19 CRYSTALLINE FORM III OF THE N- (4-DIMETHYLAMINONAFTALEN-1 SULPHONYLAMINE) PHENYL) -3-HYDROXI-2,2-DIMETHYLPROPIONAMIDE

Country Status (8)

Country Link
AR (1) AR024797A1 (en)
AU (1) AU6562600A (en)
CO (1) CO5180571A1 (en)
DE (1) DE19934295A1 (en)
GT (1) GT200000114A (en)
PE (1) PE20010382A1 (en)
UY (1) UY26251A1 (en)
WO (1) WO2001007404A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780794B2 (en) 2000-01-20 2004-08-24 Honeywell International Inc. Methods of bonding physical vapor deposition target materials to backing plate materials
US6698647B1 (en) 2000-03-10 2004-03-02 Honeywell International Inc. Aluminum-comprising target/backing plate structures
US7371906B2 (en) 2004-08-24 2008-05-13 Eastman Kodak Company Process for photo-oxidative stability improvements
EP2481540B1 (en) 2011-01-28 2017-11-01 Schelling Anlagenbau GmbH Device for sawing at least two plate or plate stack shaped workpieces

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL341815A1 (en) * 1998-01-23 2001-05-07 Bayer Ag Novel naphtyl- and anilide-susbtituted sulphonamides

Also Published As

Publication number Publication date
WO2001007404A1 (en) 2001-02-01
GT200000114A (en) 2002-01-01
AR024797A1 (en) 2002-10-23
DE19934295A1 (en) 2001-01-25
PE20010382A1 (en) 2001-06-11
UY26251A1 (en) 2001-01-31
AU6562600A (en) 2001-02-13

Similar Documents

Publication Publication Date Title
ATE270817T1 (en) FUNGICIDES
ATE245636T1 (en) BENZOFURYLPIPERAZINE: 5-HT2C SEROTONINE RECEPTOR AGONISTS
TR199901653T2 (en) Phthalazinones.
UY34152A (en) ? SUBSTITUTED OXAZOLIDINONES AND ITS USE ?.
RS49688B (en) New 3-aryl-2-hydroxypropionic acid derivative (i)
PT931788E (en) METALOPROTEASE INHIBITORS
SE0004245D0 (en) Novel compounds and their use
SE9702773D0 (en) Novel compounds
NO20030098D0 (en) &lt;Beta&gt; 3 adrenergic agonists
EE200400104A (en) N- (3-Butyn-1-yl) -N-hydroxyurea
TR200201128T2 (en) Tetrahydrothiopyraniphalazinone derivatives as PDE4 inhibitors.
DZ2576A1 (en) Parenteral compositions of alatrofloxacin.
DK1204659T3 (en) Serotonergic benzofurans
SE9903290D0 (en) Novel compounds
ATE287403T1 (en) 6-PHENYLBENZONAPHTHYIDINE
CO5180571A1 (en) CRYSTALLINE FORM III OF THE N- (4-DIMETHYLAMINONAFTALEN-1 SULPHONYLAMINE) PHENYL) -3-HYDROXI-2,2-DIMETHYLPROPIONAMIDE
ATE280169T1 (en) SEROTONERGIC BENZOTHIOPHENES
NO20011664L (en) High purity composition comprising (7 &lt;alpha&gt;, 17 &lt;alpha&gt;) - 17-hydroxy-7-methyl-19-nor-17-pregn-5 (10) -en-20-yn-3-one
CO5090902A1 (en) PIRROLES REPLACED
IT1313850B1 (en) HIGH EFFICIENCY &#34;HIGH SIDE&#34; CIRCUIT.
DE59803066D1 (en) SUBSTITUTED BENZYLOXYIMINO COMPOUNDS
PA8524001A1 (en) PROCESS TO PREPARE 2- (4-PIRIDIL) AMINO-6-DIALQUYLOXYPHENYL-PIRIDO (2,3-D) PIRIMIDIN-7-ONAS
CO5160316A1 (en) N-OXIDES OF THE CORRESPONDING FREE BASES INHIBITORS OF PHOSPHODIESTERASE IV AND ITS USE FOR THE TREATMENT OF INFLAMMATORY DISEASES
NO20020886D0 (en) Novel integrin &lt;alfa&gt; v &lt;beta&gt; 3 inhibitors
DE50107198D1 (en) EXPANSION OF THE PERFORMANCE FEATURE &#34;REPRODUCTION&#34;

Legal Events

Date Code Title Description
FA Application withdrawn